The Know AML website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and Know AML cannot guarantee the accuracy of translated content. Know AML and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
What are the takeaways for patients from the EBMT 2020 meeting?
Chris Lewis
September 2, 2020
During the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), Know AML spoke to Chris Lewis, Chris's Cancer Community (www.chris-cancercommunity.com), about the work that EBMT does both in Europe and internationally. In this video, Chris Lewis highlights the importance of patient involvement at every stage of cancer research and treatment development. EBMT is a great forum to allow patients and clinicians to get together and discuss recent advances in the field of bone marrow transplant and cancer in general. We asked, What are the key takeaways for patients from the EBMT 2020 meeting?
To what extent do you agree with the following statements?
Please rate between 1 and 5, with 1 being 'strongly disagree' and 5 being 'strongly agree'.
